Originally posted at http://www.sfgate.com
October 19, 2012, By Elizabeth Lopatto,

Three studies set to explore the use of experimental drugs that may become the first to change the course of Alzheimer’s disease aren’t looking to cure the illness. Their goal is to prevent it altogether.

The independent trials will begin in 2013 and run for three to five years, testing as many as five drugs in almost 1,500 volunteers who haven’t shown any of Alzheimer’s mind-altering symptoms, yet carry a strong genetic risk for the disease or display early physical evidence in the brain. A decision on the final study drug is expected in December.

Read the full story at http://www.sfgate.com.